The Spectrum of Infections in Patients with Lung Cancer.
Cancer Invest
; 41(1): 25-42, 2023 Jan.
Article
em En
| MEDLINE
| ID: mdl-36445108
ABSTRACT
Although diagnostic and therapeutic advances in lung cancer (LC) have increased the survival of patients, infection and its complications are still among the most important causes of mortality. The disruption of tissue caused by tumor mass, management of cancer therapy and alteration in the humoral/cellular immune systems due to both cancer itself and therapy considerably increase susceptibility to infection in cancer patients. Particularly, opportunistic microorganisms should be considered, then applying rapid and sensitive diagnostic methods for them. Thus, cancer patients who are already exposed to difficult, long-term and expensive treatments can be prevented from dying from complications related to infections.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Pulmonares
Limite:
Humans
Idioma:
En
Revista:
Cancer Invest
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Turquia